<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Middle East J Dig Dis</journal-id><journal-id journal-id-type="iso-abbrev">Middle East J Dig Dis</journal-id><journal-id journal-id-type="publisher-id">Middle East J Dig Dis</journal-id><journal-id journal-id-type="pmc">MEJDD</journal-id><journal-id journal-id-type="publisher-id">MEJDD</journal-id><journal-title-group><journal-title>Middle East Journal of Digestive Diseases</journal-title></journal-title-group><issn pub-type="ppub">2008-5230</issn><issn pub-type="epub">2008-5249</issn><issn-l>2008-5230</issn-l><publisher><publisher-name>Iranian Association of Gastroerterology and Hepatology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4208930</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The Characteristics of Rare Codon Clusters in the Genome and Proteins of Hepatitis C Virus; a Bioinformatics Look</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fattahi</surname><given-names>Mohammadreza</given-names></name><xref ref-type="aff" rid="A01"><sup>1</sup>
</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Malekpour</surname><given-names>Abdorrasoul</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mortazavi</surname><given-names>Mojtaba</given-names></name><xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Safarpour</surname><given-names>Alireza</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Naseri</surname><given-names>Nasrin</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="A01"><sup>1</sup> Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
</aff><aff id="A02"><sup>2</sup> Department of Biotechnology, Institute of Science and High Technology and Environmental Science, Graduate University of Advanced Technology, Kerman, Iran
</aff><author-notes><corresp id="COR1"><label>*</label><bold>Corresponding Author:</bold> Mohammadreza Fattahi, MD Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, P.O. Box: 71935-1311, Shiraz, Iran Telefax: + 98 71 36474263 <email>Fattahim@sums.ac.ir</email></corresp></author-notes><pub-date pub-type="ppub"><month>10</month><year>2014</year></pub-date><volume>6</volume><issue>4</issue><fpage>214</fpage><lpage>227</lpage><history><date date-type="received"><day>03</day><month>6</month><year>2014</year></date><date date-type="accepted"><day>12</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2014 by Middle East Journal of Digestive Diseases</copyright-statement><copyright-year>2014</copyright-year><license><license-p>
This work is published by Middle East Journal of Digestive Diseases as an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>). Non-commercial uses of the work are permitted, provided the original work is properly cited.
</license-p></license></permissions><self-uri xlink:href="http://mejdd.org">http://mejdd.org</self-uri><abstract><p>BACKGROUND</p><p> Recent studies suggest that rare codon clusters are functionally important for protein activity. </p><p>
METHODS
</p><p>
Here, for the first time we analyzed and reported rare codon clusters in Hepatitis C Virus (HCV) genome and then identified the location of these rare codon clusters in the structure of HCV protein. This analysis was performed using the Sherlocc program that detects statistically relevant conserved rare codon clusters.
</p><p>
RESULTS
</p><p>By this program, we identified the rare codon cluster in three regions of HCV genome; NS2, NS3, and NS5A coding sequence of HCV genome. For further understanding of the role of these rare codon clusters, we studied the location of these rare codon clusters and critical residues in the structure of NS2, NS3 and NS5A proteins. We identified some critical residues near or within rare codon clusters. It should be mentioned that characteristics of these critical residues such as location and situation of side chains are important in assurance of the HCV life cycle. </p><p>
CONCLUSION
</p><p>
The characteristics of these residues and their relative status showed that these rare codon clusters play an important role in proper folding of these proteins.
</p><p>
Thus, it is likely that these rare codon clusters may have an important role in the function of HCV proteins. This information is helpful in development of new avenues for vaccine and treatment protocols.
</p></abstract><kwd-group><kwd>HCV genome</kwd><kwd>NS2,NS3 and NS5A proteins</kwd><kwd>Rare codon cluster</kwd><kwd>Sherlocc program</kwd><kwd>Ribosomal pauses</kwd></kwd-group><counts><fig-count count="8"/><table-count count="3"/><ref-count count="57"/><page-count count="14"/></counts></article-meta><notes><p> Please cite this paper as:</p><p>FattahiMR, MalekpourAR, MortazaviM, SafarpourAR, Naseri N.The Characteristics of Rare Codon Clusters in the Genome and Proteins of Hepatitis C Virus; a Bioinformatics Look. Middle East J Dig Dis 2014;6:214-27.</p></notes></front><body><sec sec-type="introduction" id="s1"><title>INTRODUCTION</title><p>
Coding nucleotide sequences carry an integral message containing several different types of information for the various molecular mechanisms&#x0200f;.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> Recent studies also suggest that beyond the amino-acid sequence lies an additional layer of information, hidden within the codon sequence, able to mediate local kinetics of translation.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Studies of these hidden information in codon sequences, can reveal the molecular evolution of organisms, and provide insights into the functional categories and histories of genes in a genome.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Codon-usage analysis can also contribute to understanding the interaction between RNA viruses and the immune response of the hosts.<sup><xref rid="R2" ref-type="bibr">2</xref></sup>
</p><p>
Although each codon is specific for only one amino acid (or one stop signal), the genetic code is described as degenerate, or redundant because a single amino acid may be coded by more than one codon. Such groups of codons coding for a single amino acid are known as synonymous codons. For instance, six synonymous codons can produce the amino acid leucine. By contrast, a non-degenerate code, like for the amino acids methionine and tryptophan, is one for one: each code is unique, producing one and only one output. In total, 18 of the 20 amino acids can be encoded by more than one codon and most of this degeneracy is found at the third position in a codon. Synonymous codons encoding for a particular amino acid are very well conserved over most species although a few small exceptions have been reported.<sup><xref rid="R3" ref-type="bibr">3</xref>,<xref rid="R4" ref-type="bibr">4</xref></sup>
</p><p>
Codon usage bias refers to differences in the frequency of occurrence of synonymous codons in coding DNA. Different factors have been proposed to explain the preferential usage of a subset of synonymous codons, including biased mutation pressure,<sup><xref rid="R5" ref-type="bibr">5</xref></sup> difference in mutational bias between the leading and lagging strands of DNA replication,<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R7" ref-type="bibr">7</xref></sup> and natural selection for optimizing translation process (translational selection).<sup><xref rid="R8" ref-type="bibr">8</xref></sup> While some codons are preferentially used in highly expressed genes, some codons are almost absent. These codons are referred to in the literature as rare, unflavored or low usage codons. Some reports indicate synonymous codons used with low frequency tend to have depleted concentration of tRNAs.<sup><xref rid="R9" ref-type="bibr">9</xref>-<xref rid="R11" ref-type="bibr">11</xref></sup> Dereased tRNAs concentration, influence ribosomes to pause at rare codons until the rare activated tRNA brings the next amino acid to the growing polypeptide.<sup><xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R13" ref-type="bibr">13</xref></sup> It was observed that the distribution of rare triplets along mRNAs is definitely non-uniform. The observation that rare codons are not randomly distributed, but rather organized in large clusters<sup><xref rid="R14" ref-type="bibr">14</xref></sup> across species support the existence of a selective evolutionary pressure.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The clustering of rare or un-favored codons near the start codon was first identified by Ikemura<sup><xref rid="R16" ref-type="bibr">16</xref></sup> in the highly expressed ribosomal protein genes rplK, rplJ, and rpsM. This was attributed to some functional constraint, perhaps a signal for special regulation.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Several studies focused on identifying rare codons in protein sequences and replacing them with frequent synonymous ones.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> The results of studies, based on the identity, density and location of the rare codons, were diverse: change in substrate specificity,<sup><xref rid="R18" ref-type="bibr">18</xref></sup> decrease in protein solubility,<sup><xref rid="R19" ref-type="bibr">19</xref></sup> activation of a gene designed to detect misfolded proteins <sup><xref rid="R19" ref-type="bibr">19</xref></sup> and a decrease of a protein&#x02019;s specific activity.<sup><xref rid="R20" ref-type="bibr">20</xref></sup> It has been proposed that translational pauses may have evolved to secure the independent functionally competent folding of some regions of polypeptide chains during their synthesis.<sup><xref rid="R21" ref-type="bibr">21</xref></sup>
</p><p>
The hepatitis C virus (HCV) is a small, enveloped, single-stranded, positive-sense RNA virus. It is a member of the hepacivirus genus in the family Flaviviridae.<sup><xref rid="R22" ref-type="bibr">22</xref></sup> It consists of a 9.6 kb RNA, which contains an open reading frame (ORF) encoding a polyprotein, flanked by un-translated regions (UTR) at both ends .<sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref></sup> The HCV genome encodes a polyprotein precursor of about 3000 amino acids.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> The polyprotein is cleaved by the cellular signal peptidase and virally encodes two proteases into at least 10 mature proteins; core, envelope glycoprotein 1 (E1), E2, p7, nonstructural protein 2 (NS2), NS3, NS4A, NS4B, NS5A, and NS5B.<sup><xref rid="R26" ref-type="bibr">26</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup> No prophylactic HCV vaccine is currently available and increasing efforts are, therefore, needed in the development of an effective vaccine against HCV.
</p><p>
Previously, two rare codons have been detected in the HCV.<sup><xref rid="R28" ref-type="bibr">28</xref></sup> Because of an increasing amount of evidence suggesting that rare codon clusters are functionally important for protein activity,<sup><xref rid="R29" ref-type="bibr">29</xref></sup> in the present study for the first time we studied the rare codon clusters and their locations in structures of HCV proteins. For this, we identified the Pfam accession number of 10 mature HCV proteins; core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B by use of HCVpro database (HCV protein interaction database).<sup><xref rid="R30" ref-type="bibr">30</xref></sup> Subsequently, these Pfams accession numbers were analyzed in Sherlocc program.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Sherlocc program detects statistically relevant conserved rare codon clusters and produces an HTML output.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Analyses of these sequences show that several sites of HCV genome (NS2, NS3, NS4B, NS5A, and NS5B) have a rare codon cluster. Subsequently, the structures of TrEMBL entries that are reported in the output of Sherlocc program were studied in PDB database. The results of these studied shows that PDB structures of HCV proteins are not complete just as TrEMBL entries reported in Sherlocc Program outputs. For this reason, by submission of NS2, NS3, NS4B, NS5A, and NS5B sequences with these TrEMBL entries in Swiss Model Alignment interface protein modeling server,<sup><xref rid="R31" ref-type="bibr">31</xref></sup> 3D structure models were obtained. 3D structures of the HCV proteins and locations of rare codon clusters were visualized and studied using PyMOL software.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> The major influence of codon usage is on local translation rate, and large clusters will a greater effect on protein production than an equivalent number of randomly scattered rare codons.<sup><xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> Reports of improved folding yield or protein activity due to translational pausing <sup><xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref></sup> infer that potential factors might lead to the enrichment of rare codon clusters. These results imply the role of rare codon clusters in all aspects of protein expression: mRNA stability, folding, secretion, and interactions with partner proteins.<sup><xref rid="R15" ref-type="bibr">15</xref></sup> The results of these studies show that one hidden layer of codon usage information lies in the rare codon clusters and we believe studying rare codon clusters and their locations in the structure of HCV mRNA and proteins may help in the development of new and effective drugs in the future.
</p></sec><sec sec-type="materials|methods" id="s2"><title>MATERIALS AND METHODS</title><sec id="s2-1"><title>
Detection of rare codon clusters
</title><p>
The protein family accession number (Pfam) of 10 mature HCV proteins; core, E1, E2, p7, NS2, NS3, NS4A, NS4B, NS5A, and NS5B were identified using HCVpro database <sup><xref rid="R30" ref-type="bibr">30</xref></sup> and listed in <xref ref-type="table" rid="T1">table 1</xref>. The analysis and detection of the codon clusters of these Pfam IDs was done in Sherlocc program. For this, Sherlocc retrieves the nucleotide sequence of every protein in each Pfam protein family alignments from the European Nucleotide Archive (ENA) database.<sup><xref rid="R37" ref-type="bibr">37</xref></sup> Then, using the appropriate translation table the correspondence of the nucleotide sequence with the amino-acid sequence provided in the Pfam alignment is verified and the specie codon usage frequencies are retrieved using the Kazusa codon usage frequency online database.<sup><xref rid="R38" ref-type="bibr">38</xref></sup> To detect rare codon clusters, a 7 codon-wide window, is centered at every position of the alignment, and averages all codon usage frequencies inside the 7 codon-wide windows. This average calculated across all proteins of the alignment has subsequently the net effect of assuring that only positions that are rare across the majority of the members of the family are retained.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> From this, the threshold can be chosen and will allow us to discriminate positions of the alignment occupied by rare codons. All codon usage frequency averages under this threshold are tagged as slow.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Estimated locus&#x02019;s of these rare codon clusters in HCV genomic RNA is shown in <xref ref-type="fig" rid="F1">figure 1</xref> and HTML output of Sherlocc program is shown in <xref ref-type="fig" rid="F2">figure 2</xref>. The rare codon clusters characteristics in HCV proteins are listed in <xref ref-type="table" rid="T2">table 2</xref>.
</p><table-wrap id="T1" orientation="portrait" position="float"><label>
Table 1
</label><caption><title>
The characteristic of PFAM ID and rare codon clusters in HCV.
</title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 1px 0px 1pt 0px ; border-style:solid none solid none;border-color:#00adee"><td rowspan="1" colspan="1">
<bold>HCV protein</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>PFAM ID</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Number rare codon clusters</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>codon usage average threshold</bold>
</td></tr><tr><td rowspan="1" colspan="1">Core</td><td align="center" rowspan="1" colspan="1">Pf0154, Pf01543</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">E1</td><td align="center" rowspan="1" colspan="1">PF01539</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">E2</td><td align="center" rowspan="1" colspan="1">PF01560</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">P7</td><td align="center" rowspan="1" colspan="1">Not detected</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">NS2</td><td align="center" rowspan="1" colspan="1">PF01538</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">NS3</td><td align="center" rowspan="1" colspan="1">PF02907</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">NS4A</td><td align="center" rowspan="1" colspan="1">PF01006</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td rowspan="1" colspan="1">NS4B</td><td align="center" rowspan="1" colspan="1">PF01001</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">18</td></tr><tr><td rowspan="1" colspan="1">
NS5A<break/>NS5A<break/>NS5A
</td><td align="center" rowspan="1" colspan="1">
Pf01506,<break/>Pf08300,<break/>Pf08301
</td><td align="center" rowspan="1" colspan="1">
0<break/>1<break/>1
</td><td align="center" rowspan="1" colspan="1">
-<break/>18<break/>18
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">NS5B</td><td align="center" rowspan="1" colspan="1">PF00998</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">18</td></tr></tbody></table></table-wrap><fig id="F1" orientation="portrait" position="float"><label>
Fig. 1
</label><graphic xlink:href="MEJDD-6-214-g001"/><statement><p>A schematic diagram of the HCV genome, the 5' and 3' un-translated regions (UTR) shown with putative secondary structures. The long open reading frame of HCV genomic marked as a long box, in which estimated loci of rare codon clusters labeled.</p></statement></fig><fig id="F2" orientation="portrait" position="float"><label>
Fig. 2
</label><graphic xlink:href="MEJDD-6-214-g002"/><statement><p>
Extract of an HTML output A (NS2-PF01538), B1, B2, B3 (NS3-PF02907), C1 (NS5A-PF08301) and C2 (NS5A-PF08300) generated by Sherlocc program. Each row represents a protein from the alignment and displays the amino acid, its corresponding codon and the corresponding codon usage frequency (bold). At the bottom (gray row), codon usage frequency averages calculated at each position by the first window are displayed in bold. Averages under the selected threshold are considered &#x02018;slow&#x02019; and tagged in orange.<sup><xref rid="R2" ref-type="bibr">2</xref></sup>
</p></statement></fig><table-wrap id="T2" orientation="portrait" position="float"><label>
Table 2
</label><caption><title>
The output of Sherlocc program and rare codon clusters characteristics in HCV proteins.
</title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 1px 0px 1pt 0px ; border-style:solid none solid none;border-color:#00adee"><td rowspan="1" colspan="1">
<bold>HCV protein</bold>
</td><td rowspan="1" colspan="1">
<bold>PFAM ID</bold>
</td><td rowspan="1" colspan="1">
<bold>Swiss-Prot or TrEMBlentries</bold>
</td><td rowspan="1" colspan="1">
<bold>Organism</bold>
</td><td rowspan="1" colspan="1">
<bold>Number proteins</bold>
</td><td rowspan="1" colspan="1">
<bold>Residue length of the alignment</bold>
</td><td rowspan="1" colspan="1">
<bold>
RCC<sup>*</sup> Position
</bold>
</td><td rowspan="1" colspan="1">
<bold>RCC Usage Frequency Average</bold>
</td><td rowspan="1" colspan="1">
<bold>RCC Middle Point</bold>
</td><td rowspan="1" colspan="1">
<bold>Fraction of the pfam occupied by rare codon clusters</bold>
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">Core</td><td rowspan="1" colspan="1">Pf0154</td><td rowspan="1" colspan="1">Q69422 (POLG_GBVB)</td><td rowspan="1" colspan="1">Hepatitis GB virus B</td><td rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1">76</td><td rowspan="1" colspan="1">24 &#x02013; 44 64 - 68</td><td rowspan="1" colspan="1">
16.028<break/>17.354
</td><td rowspan="1" colspan="1">
33<break/>65
</td><td rowspan="1" colspan="1">0.3421052632</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">NS2</td><td rowspan="1" colspan="1">PF01538</td><td rowspan="1" colspan="1">A8DF36_9HEPC</td><td rowspan="1" colspan="1">Hepatitis C virus subtype 1b</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">203</td><td rowspan="1" colspan="1">36-45</td><td rowspan="1" colspan="1">17.983</td><td rowspan="1" colspan="1">40</td><td rowspan="1" colspan="1">0.0492610837</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">NS3</td><td rowspan="1" colspan="1">PF02907</td><td rowspan="1" colspan="1">Q9QIX6_9HEPC</td><td rowspan="1" colspan="1">Hepatitis C virus subtype 1b</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">150</td><td rowspan="1" colspan="1">
7-14<break/>41-45<break/>77-81
</td><td rowspan="1" colspan="1">
17.305<break/>17.679<break/>16.938
</td><td rowspan="1" colspan="1">
10<break/>42<break/>75
</td><td rowspan="1" colspan="1">0.1200000000</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">NS4B</td><td rowspan="1" colspan="1">PF01001</td><td rowspan="1" colspan="1">
Q69422<bold>(</bold>POLG_GBVB)
</td><td rowspan="1" colspan="1">Hepatitis GB virus B</td><td rowspan="1" colspan="1">3</td><td rowspan="1" colspan="1">199</td><td rowspan="1" colspan="1">59-63</td><td rowspan="1" colspan="1">17.318</td><td rowspan="1" colspan="1">60</td><td rowspan="1" colspan="1">0.0251256281</td></tr><tr><td rowspan="1" colspan="1">NS5A</td><td rowspan="1" colspan="1"> Pf01506</td><td rowspan="1" colspan="1"> -</td><td rowspan="1" colspan="1"> -</td><td rowspan="1" colspan="1"> -</td><td rowspan="1" colspan="1"> - </td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1"> - </td><td rowspan="1" colspan="1">-</td><td rowspan="1" colspan="1">
-
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
Pf08300
</td><td rowspan="1" colspan="1"> Q1KL41-9HEPC</td><td rowspan="1" colspan="1"> Hepatitis C virus subtype 6a </td><td rowspan="1" colspan="1"> 8</td><td rowspan="1" colspan="1"> 64</td><td rowspan="1" colspan="1"> 47-53</td><td rowspan="1" colspan="1"> 16.873 </td><td rowspan="1" colspan="1">49</td><td rowspan="1" colspan="1">
0.1093750000
</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
Pf08301
</td><td rowspan="1" colspan="1"> Q1KL34_9HEPC</td><td rowspan="1" colspan="1"> Hepatitis C virus subtype 6a</td><td rowspan="1" colspan="1"> 6 </td><td rowspan="1" colspan="1">103</td><td rowspan="1" colspan="1"> 84-87 </td><td rowspan="1" colspan="1">17.405</td><td rowspan="1" colspan="1"> 85 </td><td rowspan="1" colspan="1">
0.0388349515
</td></tr><tr><td rowspan="1" colspan="1">
NS5B
</td><td rowspan="1" colspan="1"> PF00998</td><td rowspan="1" colspan="1"> Q69422 (POLG_GBVB)</td><td rowspan="1" colspan="1"> Hepatitis GB virus B </td><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1"> 545</td><td rowspan="1" colspan="1"> 3-7 </td><td rowspan="1" colspan="1"> 4 </td><td rowspan="1" colspan="1">17.930</td><td rowspan="1" colspan="1">
0.1339449541
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
15-21
</td><td rowspan="1" colspan="1"> 17 </td><td rowspan="1" colspan="1">
17.007
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
35-45
</td><td rowspan="1" colspan="1"> 39 </td><td rowspan="1" colspan="1">
17.814
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">91-95 </td><td rowspan="1" colspan="1"> 92 </td><td rowspan="1" colspan="1">17.598</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">104-107</td><td rowspan="1" colspan="1"> 105 </td><td rowspan="1" colspan="1">
16.697
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
116-119
</td><td rowspan="1" colspan="1"> 117 </td><td rowspan="1" colspan="1">
17.472
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
172-175
</td><td rowspan="1" colspan="1"> 173 </td><td rowspan="1" colspan="1">
17.261
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
316-322
</td><td rowspan="1" colspan="1"> 318 </td><td rowspan="1" colspan="1">
18.033
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
418-422
</td><td rowspan="1" colspan="1"> 419 </td><td rowspan="1" colspan="1">
17.196
</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"> 439-448</td><td rowspan="1" colspan="1">443 </td><td rowspan="1" colspan="1">17.542</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">514-524</td><td rowspan="1" colspan="1">518</td><td rowspan="1" colspan="1">17.675</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>*</sup>RCC: Rare codon cluster.
</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>
Analysis of rare codon clusters in the structure of HCV proteins
</title><p>
To investigate the position of rare codon clusters in the structure of HCV proteins, the structures of TrEMBL entries proteins that were reported in Sherlocc program were studied in PDB database. The results showed that PDB structures of HCV proteins and their sequences are not complete and are just as TrEMBL entries sequences reported in Sherlocc Program. For this reason, by submission of TrEMBL entries sequences of NS2, NS3, NS4B, NS5A, and NS5B in Swiss Model Alignment interface protein modeling server,<sup><xref rid="R31" ref-type="bibr">31</xref></sup> 3D structure models were obtained. Modeled residue range, used templates, sequence identity and other detail information were listed in <xref ref-type="table" rid="T3">table 3</xref>. 3D structures of the HCV proteins and locations of rare codon clusters were visualized and studied using PyMOL software <sup><xref rid="R32" ref-type="bibr">32</xref></sup> as shown in <xref ref-type="fig" rid="F3"> figures 3</xref>, <xref ref-type="fig" rid="F4"> 4</xref> and <xref ref-type="fig" rid="F5">5</xref>.
</p><table-wrap id="T3" orientation="portrait" position="float"><label>
Table 3
</label><caption><title>
The characteristics of HCV protein modeling
</title></caption><table frame="hsides" rules="none"><tbody><tr style="border-width: 1px 0px 1pt 0px ; border-style:solid none solid none;border-color:#00adee"><td rowspan="1" colspan="1">
<bold>HCV Protein</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Modeled residue range</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Based on template</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Sequence Identity [%]</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>E value</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>QMEAN Z-Score</bold>
</td></tr><tr><td rowspan="1" colspan="1">NS2</td><td align="center" rowspan="1" colspan="1">27-59</td><td align="center" rowspan="1" colspan="1">2kwtA</td><td align="center" rowspan="1" colspan="1">87.88</td><td align="center" rowspan="1" colspan="1">5.56e-10</td><td align="center" rowspan="1" colspan="1">-3.59</td></tr><tr><td rowspan="1" colspan="1">NS3</td><td align="center" rowspan="1" colspan="1">1 to 149</td><td align="center" rowspan="1" colspan="1">4a1xA</td><td align="center" rowspan="1" colspan="1">96.64</td><td align="center" rowspan="1" colspan="1">5.69e-76</td><td align="center" rowspan="1" colspan="1">0.05</td></tr><tr style="border-width: 0px 0px 1pt 0px ; border-style:none none solid none;border-color:#00adee"><td rowspan="1" colspan="1">
NS5A-Q1KL41-9HEPC<break/>NS5A-Q1KL34_9HEPC
</td><td align="center" rowspan="1" colspan="1">
36 to 198<break/>36 to 198
</td><td align="center" rowspan="1" colspan="1">
1zh1B<break/>1zh1B
</td><td align="center" rowspan="1" colspan="1">
77.3<break/>76.69
</td><td align="center" rowspan="1" colspan="1">
2.38e-71<break/>1.65e-71
</td><td align="center" rowspan="1" colspan="1">
-0.93<break/>-0.81
</td></tr></tbody></table></table-wrap><fig id="F3" orientation="portrait" position="float"><label>
Fig. 3
</label><graphic xlink:href="MEJDD-6-214-g003"/><statement><p> Molecular model of the NS2 HCV [27-59]. The structure is in blue, except rare codon cluster that is in green.</p></statement></fig><fig id="F4" orientation="portrait" position="float"><label>
Fig. 4
</label><graphic xlink:href="MEJDD-6-214-g004"/><statement><p>
The ribbon diagram of NS3 protease domain and location of rare codon cluster residues. The overall
structure is in blue, except rare codon clusters B1 (V36-F43) in red, B2 (P70-M74) in yellow and B3 (L106-
H110) in green. Notice that PyMOL software could not show the region of rare codon cluster B2 and we used
spdbv(45) software for studying this region.
</p></statement></fig><fig id="F5" orientation="portrait" position="float"><label>
Fig. 5
</label><graphic xlink:href="MEJDD-6-214-g005"/><statement><p>
Part of N-terminal domain sequence from NS2 protein. Location of rare codon clusters (highlighted in green) and some essential
residues (red)
</p></statement></fig></sec></sec><sec sec-type="results" id="s3"><title>RESULTS</title><sec id="s3-1"><title>
Detection of rare codon clusters
</title><p>
With use of HCVpro database the Pfam accession numbers of 10 mature HCV proteins were identified. Pfam is a comprehensive collection of protein domains and families represented as multiple sequence alignments and as profile hidden Markov models.<sup><xref rid="R39" ref-type="bibr">39</xref></sup> After detecting Pfam IDs of HCV proteins, these Pfams were studied in the Sherlocc program. Results of these studies show that this program did not identify rare codon clusters in the envelope glycoproteins 1 (E1), E2, p7 and nonstructural protein NS4A. By contrast the rare codon clusters were identified in the core, nonstructural protein NS2, NS3, NS4B, NS5A and NS5B. The HCVpro database<sup><xref rid="R30" ref-type="bibr">30</xref></sup> detected two Pfams for core protein and analyzing the Pf01543 ID in the Sherlocc program detected no rare codon cluster while the Pf0154ID showed two rare codon clusters. For NS5A, the HCVpro database detected three Pfams (Pf01506, Pf08300 and Pf08301). Studying these Pfams shows that Pf01506 ID has no rare codon cluster while the rare codon clusters were identified in the Pf08300 and Pf08301 IDs. However in HCVpro database no Pfam was identified for P7 and therefore the Sherlocc program could not identify the rare codon cluster in this region of RNA sequence. By analyzing the PF01539, PF01560, PF01006 and Pf01506 IDs in this program, rare codon clusters were not detected in these regions of RNA sequences. However, Sherlocc program detects statistically relevant conserved rare codon clusters and more precise studies might be needed for proving these results. The Pfam ID, number of rare codon clusters and codon usage average threshold are listed in <xref ref-type="table" rid="T1">table 1</xref>.
</p><p>
The Sherlocc program produces an HTML output that reports the TrEMBL entries. Studying these TrEMBL entries showed that some of the relevant conserved rare codon clusters do not cover the TrEMBL entries from HCV proteins and eventually we gave up these rare codon clusters. According to this thread, we did not consider the results of Sherlocc program analysis for core, NS4B and NS5B Pfam IDs. The Pfam ID, Swiss-Prot or TrEMBL entries, organism, rare codon clusters position usage and other detail information are listed in <xref ref-type="table" rid="T2">table 2</xref>. It is important that rare codon cluster position reported in this table be based on the first TrEMBL entries.
</p></sec><sec id="s3-2"><title>
Analysis positions of rare codon clusters in HCV mRNA sequences
</title><p>
HCV has positive sense single-strand RNA genome. The genome composes a single open reading frame that is 9600 nucleotide bases long.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> This single open reading frame is translated to produce one protein product, which is then further processed to produce smaller active proteins. As previously mentioned, we identified six rare codon clusters in HCV genomic RNA found in the NS2, NS3 and NS5A regions of RNA. <xref ref-type="fig" rid="F1">Figure 1</xref> shows estimated locus&#x02019;s of these rare codon clusters in RNA genome.
</p><p>
Translation of mRNA is regulated by structural and non-structural RNA elements, and interactions with RNA-binding proteins.<sup><xref rid="R40" ref-type="bibr">40</xref></sup> One of the significant features of viral genome translation is the identification of genetic elements, either RNA sequences or protein domains, which may modulate the viral genome translation. Previously, six HCV genome elements (GE) had been identified.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> One of these GE, GE4, encodes the 5&#x02019; end of the viral NS5A gene that includes the membrane anchor domain.<sup><xref rid="R41" ref-type="bibr">41</xref></sup> The interesting point is that one rare codon cluster was found in this genome element (GE4). However, the position of rare codon clusters and their structural patterns in RNA may be important in opening new research fields for extending the possible cures for many disorders or viral infections. <xref ref-type="fig" rid="F2">Figure 2</xref> show the HTML output from Sherlocc program that reports the TrEMBL entries and the characteristic of rare codon clusters.
</p></sec><sec id="s3-3"><title>
Studying rare codon clusters in the structure of HCV proteins
</title><p>
Knowledge of 3D structure is a useful prerequisite for understanding the role and function of proteins. Studying the location and roles of rare codon clusters on the three-dimensional structure of proteins, is a cornerstone in many aspects of modern biology. The possible roles for rare codon clusters are to produce multiple translational pauses during the synthesis of its catalytic domain,<sup><xref rid="R2" ref-type="bibr">2</xref></sup> play a regulating role in folding catalytically important domains, and in protein structure and indirect folding.<sup><xref rid="R29" ref-type="bibr">29</xref>,<xref rid="R42" ref-type="bibr">42</xref></sup> Further, many results support the existence of a widespread functional role for rare codon clusters across species.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> As mentioned, six rare codon clusters were identified in HCV genome found in NS2, NS3 and NS5A of HCV proteins. Specific studies shows PDB structures of HCV proteins are not complete and are just as TrEMBL entries sequences reported in Sherlocc program outputs. Protein-protein blast show the rough location of rare codon clusters in these sequences but for precise studying of the location and role of rare codon clusters, it is necessary to gain 3D models from these sequences. To this end, by submitting sequences of NS2, NS3 and NS5A in Swiss Model alignment interface protein modeling server,<sup><xref rid="R31" ref-type="bibr">31</xref></sup> 3D models of these proteins were obtained. The modeled residue range, template and other detailed information are listed in <xref ref-type="table" rid="T3">table 3</xref>.
</p><p>
The Sherlocc program identified TrEMBL entryA8DF36_9HEPCfor NS2. Using the Swiss-Model, these TrEMBL entry sequence were used for obtaining the 3D model of this protein. NS2, derived from the cleavage of NS2/3, inserted into the ER membrane through its N-terminal hydrophobic domain suggested containing multiple transmembrane segments.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> The NS2 protein has 217 residue and rare codon clusters found from amino acids 37 to 46 and in polyproteins extending from amino acids 846-855. The overall structure of NS2 was not determined and therefore the Swiss Model could not model the whole sequence. The structure of NS2 protein has been modeled previously and in this model amino acids from 27 to 49 formed trans-membrane &#x003b1; helix (TMH-2).<sup><xref rid="R43" ref-type="bibr">43</xref></sup> Results of modeling show that this rare codon cluster is located in this trans-membrane &#x003b1; helix (TMH-2). <xref ref-type="fig" rid="F3">Figure 3</xref> shows the modeled NS2 and the position of rare codon clusters.
</p><p>
For NS3 protein, Sherlocc program identified TrEMBL entries Q9QIX6_9HEPC.The NS3 protein has 631 residue and three rare codon clusters found in polyproteins extending from amino acids 1062-1069, 1096-1100 and 1132-1136<bold>.</bold> NS3 is a multifunctional protein and the N-terminal domain (residues 1027&#x02013;1119) contains eight &#x003b2; strands rather than six, including one strand contributed by NS4A.<sup><xref rid="R44" ref-type="bibr">44</xref></sup> This array of b strands gives rise to a b sheet that superimposes with most of the distorted barrel found in the N-terminus of chymotrypsin.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> Result of modeling showed that these three rare codon clusters lie between strands A1-B1, E1-F and A2-B2 in N-terminal domain of NS3. <xref ref-type="fig" rid="F4">Figure 4</xref> shows the modeled NS3 and the position of rare codon clusters.
</p><p>
As mentioned, HCVpro database for NS5A detected three Pfams. For Pf01506 ID this database did not identify any rare codon cluster while for Pf08300 and Pf08301 IDs two rare codon clusters were identified. These rare codon clusters were found in different loci sequences of NS5A and Sherlocc program for NS5A revealed two TrEMBL entries; Q1KL41<bold>-</bold>9HEPC and Q1KL34_9HEPC. The protein was predicted to be mainly hydrophilic and contain no transmembrane helices.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> A recent study using bioinformatics assisted modeling suggested a three-domain organization with domain I (a.a. 1-213) located in the N-terminal region, and Domain II (a.a. 250-342) and Domain III (a.a. 356-447) in the C-terminal region.<sup><xref rid="R47" ref-type="bibr">47</xref></sup> Analysis of the 3D model showed that these two rare codon clusters lie in domain I located in the N-terminal of NS5A HCV. <xref ref-type="fig" rid="F5">Figure 5</xref> shows the position of these rare codon clusters in the structure of NS5A HCV proteins.
</p></sec></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>
The preliminary goal of this study was to perform a survey of rare codon clusters in the HCV genome and then identify the location of these clusters in the structure of HCV protein. Previous studies on the distribution of rare codons clusters were performed on a limited number of proteins or protein families.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> The Sherlocc program and the online Sherlocc Finder Interface are efficient tools that can be used to study the widespread translational pauses in protein families.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Please note that clusters identified by Sherlocc were compared with cases foundin the literature.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> For example, in the Salmonella phage P22 tail spike protein in which rare codons were previously identified using the MinMax algorithm,<sup><xref rid="R15" ref-type="bibr">15</xref></sup> Sherlocc also identified rare codon clusters in the Salmonella phage P22 tail-spike protein family (PF09251).<sup><xref rid="R2" ref-type="bibr">2</xref></sup> Another case involved the chloramphenicol acetyl transferase (CAT) protein for which rare codon clusters were identified computationally in a multi-organism sequence alignment of this protein.<sup><xref rid="R42" ref-type="bibr">42</xref></sup> The Sherlocc program also identified rare codon clusters in the CAT protein family (PF00302). In the present study, we used Sherlocc program to analyze rare codon clusters in HCV genome and the structure of HCV proteins. The results were interesting and showed that HCV has five rare codon clusters and these rare codon clusters may play an essential role in ensuring proper folding of the protein chain.
</p><p>
The HCV structural proteins, core, E1, and E2, were located at the amino terminus and nonstructural proteins, NS3, NS4A, NS4B, NS5A, and NS5B, were located at the carboxyl terminus. The deduced amino acid sequence of HCV nonstructural 2 shows that NS2 is a hydrophobic transmembrane protein, described to be involved in different functions.<sup><xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R48" ref-type="bibr">48</xref></sup> NS2 is a 217 amino acid long cysteine-protease composed of a hydrophobic N-terminal membrane binding domain (MBD) and C-terminal globular and cytosolic protease subdomain. Previously a model of NS2 proposed that this protein is a polytopictrans membrane protein containing 3 putative transmembrane segments.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> Many studies have been done on this protein indicating interesting results regarding the role of amino acids.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> These studies show that alanine substitutions with aromatic residue in TMS2 (Y39) reduced infectivity titers up to 1,000-fold whereas mutations introducing electrostatic repulsion in TMS2 (E45R) blocked virus production .<sup><xref rid="R43" ref-type="bibr">43</xref></sup>
</p><p>
Also, for W35F and W35FNS3- Q221L, interaction of NS2 with other viral proteins reduced, but to different extents.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> Based on the model of the NS2, residues 25 and 39, which were found on TMS1 and TMS2, respectively, might be in contact.<sup><xref rid="R43" ref-type="bibr">43</xref></sup> It assumed the &#x02018;&#x02018;hole&#x02019;&#x02019; created in TMS2 by the Y39A substitution was compensated by a bulky amino acid in the interacting TMS1 counterpart, thus &#x02018;filling up&#x02019; the hole in the mutated TMS2. A striking correlation was found between reduction of aromaticity as well as size of residues at these sites (W35 and W36) and decrease of virus production arguing the aromatic side chains of W35 and W36 involved in essential interactions. These results show that these residues play critical roles in proper folding of this protein and disrupting this process severely affected the virus life cycle. An important point deduced from our analysis was that some of these residues were involved in rare codon clusters of NS2 (<xref ref-type="fig" rid="F6">figure 6</xref>).
</p><fig id="F6" orientation="portrait" position="float"><label>
Fig. 6
</label><graphic xlink:href="MEJDD-6-214-g006"/><statement><p>
The ribbon diagram of NS3 protease domain and location of rare codon cluster residues. The overall structure is in blue,
except rare codon clusters B1 (V36-F43) in red, B2 (P70-M74) in yellow and B3 (L106-H110) in green. Notice that PyMOL software
could not show the region of rare codon cluster B2 and we used spdbv(45) software for studying this region.
</p></statement></fig><p>
As mentioned, mutation of these residues blocks or reduces virus production and this shows that the situation of side chains are important in maintaining the HCV life cycle. NS2 has a rare codon cluster found in transmembrane (TMS2). According to the characteristics of transmembrane proteins, translation and folding of TMS2 mRNA appear to be more important and may take more time for folding compared with other parts of NS2. However, these conclusions should be confirmed with experimental evidence.
</p><p>
The 631-residue HCV NS3 protein is a dual-function protein, containing the trypsin/chymotrypsin-like serine protease in the N-terminal region and a helicase in the C-terminal region.<sup><xref rid="R49" ref-type="bibr">49</xref>,<xref rid="R50" ref-type="bibr">50</xref></sup> Co-transfection studies showed the NS3 serine protease domain, in absence of its C-terminal helicase counterpart, is mediating cleavage of polyprotein substrates.<sup><xref rid="R51" ref-type="bibr">51</xref></sup> The minimal sequences needed for a serine protease activity determined by these groups is the N-terminal 180 amino acids of the NS3 protein. Deletion of up to 14 residues from the N terminus of the NS3 protein is tolerated, although a further deletion of the N-terminal 22 amino acids resulted in significantly poorer processing of HCV polyprotein. On the other hand, deletions from C terminus of this minimal serine protease domain abolished proteolytic activity.<sup><xref rid="R52" ref-type="bibr">52</xref>,<xref rid="R53" ref-type="bibr">53</xref></sup> Our study showed that NS3 protein has three rare codon clusters found in polyprotein extending from amino acids 1062-1069, 1096-1100 and 1132-1136 that lies between strands A1-B1, E1-F and A2-B2 in N-terminal domain of NS3. Full-length NS3 protein found from amino acids 1027 to 1658 of the polyprotein of the genotype 1b consensus sequence.<sup><xref rid="R54" ref-type="bibr">54</xref></sup> Previously, in the protease domain of NS3, amino acid residues involved in substrate-binding pocket were identified.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> These residues are potentially able to interact with peptide substrates.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> Studies show that some of these residues are found in rare codon cluster locus (<xref ref-type="fig" rid="F7">figure 7</xref>).
</p><fig id="F7" orientation="portrait" position="float"><label>
Fig. 7
</label><graphic xlink:href="MEJDD-6-214-g007"/><statement><p>
Part of N-terminal domain from NS3 protein. Location of rare codon cluster (highlighted in blue) and some of the substrate
binding site residues (red color) shown.
</p></statement></fig><p>
Most NS3 protease inhibitors are competitive with the substrate and thus target the substrate binding site.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> The earliest inhibitors were based on product peptides.<sup><xref rid="R56" ref-type="bibr">56</xref></sup> Many positions of NS3 protease have shown to contribute to resistance in cell culture and in the clinic.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> Many of the positions confer resistance to both macro-cyclic and linear inhibitors.<sup><xref rid="R55" ref-type="bibr">55</xref></sup> Amino acid substitutions at positions that are not essential for substrate binding would lead to drug-resistant proteases and viruses that do not debilitate for function.<sup><xref rid="R56" ref-type="bibr">56</xref></sup> Our study showed that some of residues that involved in substrate binding site and confer resistance inhibitors can be found in the first rare codon cluster and near position of other rare codon cluster. As we know, the binding site residues are critical in enzymes and proper position of these residues should be adjusted accurately. These data show that positions of rare codon clusters may play a critical role in proper folding and action of protease domain of NS3.
</p><p>
HCV nonstructural protein 5A (NS5A) plays an essential role in viral genome replication. The protein is predicted to be mainly hydrophilic and to contain no transmembrane helices.<sup><xref rid="R46" ref-type="bibr">46</xref></sup> A recent study using bioinformatics-assisted modeling suggested a three-domain organization <sup><xref rid="R47" ref-type="bibr">47</xref></sup> with domain I (a.a. 1-213) found in the N-terminal region, and Domain II (a.a. 250-342) and Domain III (a.a. 356-447) in the C-terminal region. The N-terminal 30 aa of NS5A predicted to form a conserved amphipathic alpha-helix.<sup><xref rid="R57" ref-type="bibr">57</xref></sup> Afterwards, this structure has shown to be very essential for HCV RNA replication.<sup><xref rid="R45" ref-type="bibr">45</xref></sup> Our study showed that NS5A protein has two rare codon clusters found in polyprotein extending from amino acids 2051-2061 and 2154-2157that lies in N-terminal domain (domain I) of NS5A. Full-length NS5A protein was found from amino acids 1978 to 24287 of the polyprotein of the genotype 6a consensus sequence. Previously, in the N-terminal domain of NS5A, the amino acid residues involved in activity were identified. The location of some of these residues and rare codon clusters is shown in <xref ref-type="fig" rid="F8">figure 8</xref>.
</p><fig id="F8" orientation="portrait" position="float"><label>
Fig. 8
</label><graphic xlink:href="MEJDD-6-214-g008"/><statement><p>
Part of amino acid sequences that important for activity of HCV NS5A in N-terminal domain. Location of rare codon cluster
(highlighted in green) and some of the substrate binding site residues (red color) shown.
</p></statement></fig><p>
As shown in this figure some of the residues found in the first rare codon cluster and near other rare codon clusters. Interestingly, an unconventional zinc-binding motif predicted to exist in the N-terminal domain, showing that NS5A is a zinc metalloprotein.<sup><xref rid="R47" ref-type="bibr">47</xref></sup> The predicted zinc-binding motif involves four cysteine residues (C39, C57, C59, and C80), and includes a structural motif (CX17CXCX20C). This motif appeared critical for the structural stability and functions of NS5A protein, since mutation of any single cysteine residue in the motif disrupted the ability of NS5A to coordinate zinc and eliminated RNA replication.<sup><xref rid="R47" ref-type="bibr">47</xref></sup> As we know these residues are critical in enzymes and proper position of these residues should be adjusted accurately. These data show that rare codon cluster may play a critical role in proper folding and action of protease activity. These data indicate that in HCV life cycle, rare codon clusters play an important role that must be investigated. However, other rare codon clusters may exist that could not be identified by Sherlocc program and require further study. Since most rare codon clusters were found in NS3, it appears that these clusters may play a more significant role than other HCV proteins.
</p><p>
As explained in the introduction, ribosomal pauses caused by rare codons can basically regulate specific folding events but could also be involved in other mechanisms involving the nascent polypeptide chain such as protein targeting or co-translational molecular recognition events.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> However, we cannot strictly state whether such pauses are needed for folding or molecular recognition of HCV proteins. Based on the involvement of families with rare clusters with membrane insertion or recognizing large complexes, it is suggested that those rare codon clusters are important in HCV life cycle. Proteins synthesized in a nonlinear kinetic landscape and mRNA sequence seem to carry more information than those necessary to encode protein sequences. Information that can be used for regulating folding events as well as regulating co-translational molecular recognition events such as recognizing signal peptides, formation of complexes, or membrane insertion. We believe that this study presents a new perspective in genome research of HCV. In the future, this study can also provide new fields in drug design for the treatment of HCV.
</p></sec><sec id="s5"><title>ACKNOWLEDGMENTS</title><p>
Authors wish to thank the staff of Gastroenterohepatology Research Center, Shiraz University of Medical Sciences for their kindly help in conducting of this study.
</p></sec><sec id="s6"><title>CONFLICT OF INTEREST</title><p>
The authors declare no conflict of interest related to this work.
</p></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><name><surname>Kypr</surname><given-names>J</given-names></name><article-title>A Part Of Codon Bias In Genes Protects Protein Spatial Structures From Destabilization By Random Single Point Mutations</article-title><source>Biochem Biophys Res Commun</source><year>1986</year><volume>139</volume><fpage>1094</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3767992</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><name><surname>Chartier</surname><given-names>M</given-names></name><name><surname>Gaudreault</surname><given-names>F</given-names></name><name><surname>Najmanovich</surname><given-names>R</given-names></name><article-title>Large-Scale Analysis Of Conserved Rare Codon Clusters Suggests An Involvement In Co-Translational Molecular Recognition Events</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>1438</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">22467916</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><name><surname>Shackelton</surname><given-names>La</given-names></name><name><surname>Parrish</surname><given-names>Cr</given-names></name><name><surname>Holmes</surname><given-names>Ec</given-names></name><article-title>Evolutionary Basis Of Codon Usage And Nucleotide Composition Bias In Vertebrate Dna Viruses</article-title><source>J Mol Evol</source><year>2006</year><volume>62</volume><fpage>551</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16557338</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><name><surname>Osawa</surname><given-names>S</given-names></name><name><surname>Jukes</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Muto</surname><given-names>A</given-names></name><article-title>Recent Evidence For Evolution Of The Genetic Code</article-title><source>Microbiol Rev</source><year>1992</year><volume>56</volume><fpage>229</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">1579111</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><name><surname>Santos</surname><given-names>Ma</given-names></name><name><surname>Moura</surname><given-names>G</given-names></name><name><surname>Massey</surname><given-names>Se</given-names></name><name><surname>Tuite</surname><given-names>Mf</given-names></name><article-title>Driving Change: The Evolution Of Alternative Genetic Codes</article-title><source>Trends Genet</source><year>2004</year><volume>20</volume><fpage>95</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">14746991</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><name><surname>Sueoka</surname><given-names>N</given-names></name><article-title>On The Genetic Basis Of Variation And Heterogeneity Of Dna Base Composition</article-title><source>Proc Natl Acad Sci U S A</source><year>1962</year><volume>48</volume><fpage>582</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">13918161</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><name><surname>Lobry</surname><given-names>J</given-names></name><article-title>Asymmetric Substitution Patterns In The Two Dna Strands Of Bacteria</article-title><source>Mol Biol Evol</source><year>1996</year><volume>13</volume><fpage>660</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8676740</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><name><surname>Mclean</surname><given-names>Mj</given-names></name><name><surname>Wolfe</surname><given-names>Kh</given-names></name><name><surname>Devine</surname><given-names>Km</given-names></name><article-title>Base Composition Skews, Replication Orientation, And Gene Orientation In 12 Prokaryote Genomes</article-title><source>J Mol Evol</source><year>1998</year><volume>47</volume><fpage>691</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">9847411</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><name><surname>Sharp</surname><given-names>Pm</given-names></name><name><surname>Bailes</surname><given-names>E</given-names></name><name><surname>Grocock</surname><given-names>Rj</given-names></name><name><surname>Peden</surname><given-names>Jf</given-names></name><name><surname>Sockett</surname><given-names>Re</given-names></name><article-title>Variation In The Strength Of Selected Codon Usage Bias Among Bacteria</article-title><source>Nucleic Acids Res</source><year>2005</year><volume>33</volume><fpage>1141</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15728743</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><name><surname>Ikemura</surname><given-names>T</given-names></name><article-title>Codon Usage And Trna Content In Unicellular And Multicellular Organisms</article-title><source>Mol Biol Evol</source><year>1985</year><volume>2</volume><fpage>13</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">3916708</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><name><surname>Percudani</surname><given-names>R</given-names></name><name><surname>Pavesi</surname><given-names>A</given-names></name><name><surname>Ottonello</surname><given-names>S</given-names></name><article-title>Transfer RNA gene redundancy and translational selection in Saccharomyces cerevisiae</article-title><source>J Mol Biol</source><year>1997</year><volume>268</volume><fpage>322</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">9159473</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><name><surname>Duret</surname><given-names>L</given-names></name><article-title>Trna Gene Number And Codon Usage In The CElegans Genome Are Co-Adapted For Optimal Translation Of Highly Expressed Genes</article-title><source>Trends Genet</source><year>2000</year><volume>16</volume><fpage>287</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10858656</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><name><surname>Sorensen</surname><given-names>Ma</given-names></name><name><surname>Kurland</surname><given-names>C</given-names></name><name><surname>Pedersen</surname><given-names>S</given-names></name><article-title>Codon usage determines translation rate in Escherichia coli</article-title><source>J Mol Biol</source><year>1989</year><volume>207</volume><fpage>365</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">2474074</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><name><surname>Varenne</surname><given-names>S</given-names></name><name><surname>Buc</surname><given-names>J</given-names></name><name><surname>Lloubes</surname><given-names>R</given-names></name><name><surname>Lazdunski</surname><given-names>C</given-names></name><article-title>Translation Is A Non-Uniform Process: Effect Of Trna Availability On The Rate Of Elongation Of Nascent Polypeptide Chains</article-title><source>J Mol Biol</source><year>1984</year><volume>180</volume><fpage>549</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">6084718</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><name><surname>Clarke TF</surname><given-names>4th</given-names></name><name><surname>Clark</surname><given-names>PL</given-names></name><article-title>Rare Codons Cluster</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e3412</fpage><pub-id pub-id-type="pmid">18923675</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><name><surname>Ikemura</surname><given-names>T</given-names></name><article-title>Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes</article-title><source>J Mol Biol</source><year>1981</year><volume>146</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">6167728</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><name><surname>Ikemura</surname><given-names>T</given-names></name><article-title>Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the Ecoli translational system</article-title><source>J Mol Biol</source><year>1981</year><volume>151</volume><fpage>389</fpage><lpage>409</lpage><pub-id pub-id-type="pmid">6175758</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><name><surname>Kimchi-Sarfaty</surname><given-names>C</given-names></name><name><surname>Oh</surname><given-names>JM</given-names></name><name><surname>Kim</surname><given-names>IW</given-names></name><name><surname>Sauna</surname><given-names>ZE</given-names></name><name><surname>Calcagno</surname><given-names>AM</given-names></name><name><surname>Ambudkar</surname><given-names>SV</given-names></name><etal/><article-title>A "silent" polymorphism in the MDR1 gene changes substrate specificity</article-title><source>Science</source><year>2007</year><volume>315</volume><fpage>525</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17185560</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><name><surname>Cortazzo</surname><given-names>P</given-names></name><name><surname>Cerve&#x000f1;ansky</surname><given-names>C</given-names></name><name><surname>Mar&#x000ed;n</surname><given-names>M</given-names></name><name><surname>Reiss</surname><given-names>C</given-names></name><name><surname>Ehrlich</surname><given-names>R</given-names></name><name><surname>Deana</surname><given-names>A</given-names></name><article-title>Silent mutations affect in vivo protein folding in Escherichia coli</article-title><source>Biochem Biophys Res Commun</source><year>2002</year><volume>293</volume><fpage>537</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">12054634</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><name><surname>Komar</surname><given-names>Aa</given-names></name><name><surname>Lesnik</surname><given-names>T</given-names></name><name><surname>Reiss</surname><given-names>C</given-names></name><article-title>Synonymous Codon Substitutions Affect Ribosome Traffic And Protein Folding During In Vitro Translation</article-title><source>FEBS Lett</source><year>1999</year><volume>462</volume><fpage>387</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">10622731</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><name><surname>Guisez</surname><given-names>Y</given-names></name><name><surname>Robbens</surname><given-names>J</given-names></name><name><surname>Remaut</surname><given-names>E</given-names></name><name><surname>Fiers</surname><given-names>W</given-names></name><article-title>Folding of the MS2 coat protein in Escherichia coli is modulated by translational pauses resulting from mRNA secondary structure and codon usage: a hypothesis</article-title><source>J Theor Biol</source><year>1993</year><volume>162</volume><fpage>243</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">8412226</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><name><surname>Alter</surname><given-names>MJ</given-names></name><article-title>Epidemiology Of Hepatitis C In The West</article-title><source>Semin Liver Dis</source><year>1995</year><volume>15</volume><fpage>5</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">7597444</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><name><surname>Choo</surname><given-names>Q-L</given-names></name><name><surname>Kuo</surname><given-names>G</given-names></name><name><surname>Weiner</surname><given-names>Aj</given-names></name><name><surname>Overby</surname><given-names>Lr</given-names></name><name><surname>Bradley</surname><given-names>Dw</given-names></name><name><surname>Houghton</surname><given-names>M</given-names></name><article-title>Isolation Of A Cdna Clone Derived From A Blood-Borne Non-A, Non-B Viral Hepatitis Genome</article-title><source>Science</source><year>1989</year><volume>244</volume><fpage>359</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">2523562</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Ishii</surname><given-names>K</given-names></name><name><surname>Aizaki</surname><given-names>H</given-names></name><name><surname>Wakita</surname><given-names>T</given-names></name><article-title>Hepatitis C Viral Life Cycle</article-title><source>Adv Drug Deliv Rev</source><year>2007</year><volume>59</volume><fpage>1200</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">17825945</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Hijikata</surname><given-names>M</given-names></name><name><surname>Ootsuyama</surname><given-names>Y</given-names></name><name><surname>Nakagawa</surname><given-names>M</given-names></name><name><surname>Ohkoshi</surname><given-names>S</given-names></name><name><surname>Sugimura</surname><given-names>T</given-names></name><etal/><article-title>Molecular Cloning Of The Human Hepatitis C Virus Genome From Japanese Patients With Non-A, Non-B Hepatitis</article-title><source>Proc Natl Acad Sci U S A</source><year>1990</year><volume>87</volume><fpage>9524</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">2175903</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><name><surname>Shimotohno</surname><given-names>K</given-names></name><name><surname>Tanji</surname><given-names>Y</given-names></name><name><surname>Hirowatari</surname><given-names>Y</given-names></name><name><surname>Komoda</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name><name><surname>Hijikata</surname><given-names>M</given-names></name><article-title>Processing Of The Hepatitis C Virus Precursor Protein</article-title><source>J Hepatol</source><year>1995</year><volume>22</volume><fpage>87</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7602084</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><name><surname>Reed</surname><given-names>K</given-names></name><name><surname>Rice</surname><given-names>C</given-names></name><article-title>Overview Of Hepatitis C Virus Genome Structure, Polyprotein Processing, And Protein Properties</article-title><source>Curr Top Microbiol Immunol</source><year>2000</year><volume>242</volume><fpage>55</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">10592656</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><name><surname>Hu</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>QQ</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>HT</given-names></name><name><surname>Xu</surname><given-names>ZW</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><etal/><article-title>The Characteristic Of Codon Usage Pattern And Its Evolution Of Hepatitis C Virus</article-title><source>Infect Genet Evol</source><year>2011</year><volume>11</volume><fpage>2098</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">21907310</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><name><surname>Thanaraj</surname><given-names>T</given-names></name><name><surname>Argos</surname><given-names>P</given-names></name><article-title>Protein Secondary Structural Types Are Differentially Coded On Messenger Rna</article-title><source>Protein Sci</source><year>1996</year><volume>5</volume><fpage>1973</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8897597</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><name><surname>Kwofie</surname><given-names>Sk</given-names></name><name><surname>Schaefer</surname><given-names>U</given-names></name><name><surname>Sundararajan</surname><given-names>Vs</given-names></name><name><surname>Bajic</surname><given-names>Vb</given-names></name><name><surname>Christoffels</surname><given-names>A</given-names></name><article-title>HCVpro: hepatitis C virus protein interaction database</article-title><source>Infect Genet Evol</source><year>2011</year><volume>11</volume><fpage>1971</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">21930248</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><name><surname>Schwede</surname><given-names>T</given-names></name><name><surname>Kopp</surname><given-names>J</given-names></name><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>Mc</given-names></name><article-title>SWISS-MODEL: An automated protein homology-modeling server</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>3381</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">12824332</pub-id></element-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="other">
Delano Wl. The Pymol Molecular Graphics System. 2002.
</mixed-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><name><surname>Varenne</surname><given-names>S</given-names></name><name><surname>Baty</surname><given-names>D</given-names></name><name><surname>Verheij</surname><given-names>H</given-names></name><name><surname>Shire</surname><given-names>D</given-names></name><name><surname>Lazdunski</surname><given-names>C</given-names></name><article-title>The Maximum Rate Of Gene Expression Is Dependent In The Downstream Context Of Unfavourable Codons</article-title><source>Biochimie</source><year>1989</year><volume>71</volume><fpage>1221</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">2517483</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><name><surname>Varenne</surname><given-names>S</given-names></name><name><surname>Lazdunski</surname><given-names>C</given-names></name><article-title>Effect Of Distribution Of Unfavourable Codons On The Maximum Rate Of Gene Expression By An Heterologous Organism</article-title><source>J Theor Biol</source><year>1986</year><volume>120</volume><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">3528671</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><name><surname>Tsai</surname><given-names>CJ</given-names></name><name><surname>Sauna</surname><given-names>Ze</given-names></name><name><surname>Kimchi-Sarfaty</surname><given-names>C</given-names></name><name><surname>Ambudkar</surname><given-names>Sv</given-names></name><name><surname>Gottesman</surname><given-names>Mm</given-names></name><name><surname>Nussinov</surname><given-names>R</given-names></name><article-title>Synonymous Mutations And Ribosome Stalling Can Lead To Altered Folding Pathways And Distinct Minima</article-title><source>J Mol Biol</source><year>2008</year><volume>383</volume><fpage>281</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">18722384</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><name><surname>Buchan</surname><given-names>Jr</given-names></name><name><surname>Stansfield</surname><given-names>I</given-names></name><article-title>Halting A Cellular Production Line: Responses To Ribosomal Pausing During Translation</article-title><source>Biol Cell</source><year>2007</year><volume>99</volume><fpage>475</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">17696878</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><name><surname>Leinonen</surname><given-names>R</given-names></name><name><surname>Akhtar</surname><given-names>R</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Bower</surname><given-names>L</given-names></name><name><surname>Cerdeno-T&#x000e1;rraga</surname><given-names>A</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><etal/><article-title>The European Nucleotide Archive</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><issue>Database issue</issue><fpage>D28</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">20972220</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Gojobori</surname><given-names>T</given-names></name><name><surname>Ikemura</surname><given-names>T</given-names></name><article-title>Codon Usage Tabulated From International Dna Sequence Databases: Status For The Year 2000</article-title><source>Nucleic Acids Res</source><year>2000</year><volume>28</volume><fpage>292</fpage><pub-id pub-id-type="pmid">10592250</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><name><surname>Sonnhammer</surname><given-names>El</given-names></name><name><surname>Eddy</surname><given-names>Sr</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><article-title>Pfam: A Comprehensive Database Of Protein Domain Families Based On Seed Alignments</article-title><source>Proteins</source><year>1997</year><volume>28</volume><fpage>405</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">9223186</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><name><surname>Roberts</surname><given-names>L</given-names></name><name><surname>Holcik</surname><given-names>M</given-names></name><article-title>RNA structure: new messages in translation, replication and diseaseWorkshop on the role of RNA structures in the translation of viral and cellular RNAs</article-title><source>EMBO Rep</source><year>2009</year><volume>10</volume><fpage>449</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">19343048</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><name><surname>Loic</surname><given-names>Jaffrelo</given-names></name><name><surname>Sandrine</surname><given-names>Chabas</given-names></name><name><surname>Sandrine</surname><given-names>Reigadas</given-names></name><name><surname>Aude</surname><given-names>Pflieger</given-names></name><name><surname>Czeslaw</surname><given-names>Wychowski</given-names></name><name><surname>Julie</surname><given-names>Rumi</given-names></name><etal/><article-title>A functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitors</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>e95</fpage><pub-id pub-id-type="pmid">18614605</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><name><surname>Widmann</surname><given-names>M</given-names></name><name><surname>Clairo</surname><given-names>M</given-names></name><name><surname>Dippon</surname><given-names>J</given-names></name><name><surname>Pleiss</surname><given-names>J</given-names></name><article-title>Analysis Of The Distribution Of Functionally Relevant Rare Codons</article-title><source>BMC Genomics</source><year>2008</year><volume>9</volume><fpage>207</fpage><pub-id pub-id-type="pmid">18457591</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><name><surname>Jirasko</surname><given-names>V</given-names></name><name><surname>Montserret</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>Jy</given-names></name><name><surname>Gouttenoire</surname><given-names>J</given-names></name><name><surname>Moradpour</surname><given-names>D</given-names></name><name><surname>Penin</surname><given-names>F</given-names></name><etal/><article-title>Structural And Functional Studies Of Nonstructural Protein 2 Of The Hepatitis C Virus Reveal Its Key Role As Organizer Of Virion Assembly</article-title><source>PLoS Pathog</source><year>2010</year><volume>6</volume><fpage>e1001233</fpage><pub-id pub-id-type="pmid">21187906</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Morgenstern</surname><given-names>K</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Fox</surname><given-names>T</given-names></name><name><surname>Dwyer</surname><given-names>M</given-names></name><name><surname>Landro</surname><given-names>J</given-names></name><etal/><article-title>Crystal Structure Of The Hepatitis C Virus Ns3 Protease Domain Complexed With A Synthetic Ns4a Cofactor Peptide</article-title><source>Cell</source><year>1996</year><volume>87</volume><fpage>343</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">8861917</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>Mc</given-names></name><article-title>Swiss&#x02010;Model And The Swiss&#x02010;Pdb Viewer: An Environment For Comparative Protein Modeling</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><fpage>2714</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">9504803</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><name><surname>Macdonald</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>M</given-names></name><article-title>Hepatitis C Virus Ns5a: Tales Of A Promiscuous Protein</article-title><source>J Gen Virol</source><year>2004</year><volume>85</volume><fpage>2485</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">15302943</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><name><surname>Tellinghuisen</surname><given-names>Tl</given-names></name><name><surname>Marcotrigiano</surname><given-names>J</given-names></name><name><surname>Gorbalenya</surname><given-names>Ae</given-names></name><name><surname>Rice</surname><given-names>Cm</given-names></name><article-title>The Ns5a Protein Of Hepatitis C Virus Is A Zinc Metalloprotein</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>48576</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">15339921</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><name><surname>Tomei</surname><given-names>L</given-names></name><name><surname>Failla</surname><given-names>C</given-names></name><name><surname>Santolini</surname><given-names>E</given-names></name><name><surname>De Francesco</surname><given-names>R</given-names></name><name><surname>La Monica</surname><given-names>N</given-names></name><article-title>Ns3 Is A Serine Protease Required For Processing Of Hepatitis C Virus Polyprotein</article-title><source>J Virol</source><year>1993</year><volume>67</volume><fpage>4017</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">7685406</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><name><surname>Gorbalenya</surname><given-names>Ae</given-names></name><name><surname>Koonin</surname><given-names>Ev</given-names></name><article-title>Helicases: Amino Acid Sequence Comparisons And Structure-Function Relationships</article-title><source>Curr Opin Struct Biol</source><year>1993</year><volume>3</volume><fpage>419</fpage><lpage>29</lpage></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><name><surname>Gorbalenya</surname><given-names>Ae</given-names></name><name><surname>Koonin</surname><given-names>Ev</given-names></name><name><surname>Donchenko</surname><given-names>Ap</given-names></name><name><surname>Blinov</surname><given-names>Vm</given-names></name><article-title>Two Related Superfamilies Of Putative Helicases Involved In Replication, Recombination, Repair And Expression Of Dna And Rna Genomes</article-title><source>Nucleic Acids Res</source><year>1989</year><volume>17</volume><fpage>4713</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">2546125</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Pragai</surname><given-names>Bm</given-names></name><name><surname>Grakoui</surname><given-names>A</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Rice</surname><given-names>Cm</given-names></name><article-title>Hepatitis C Virus Ns3 Serine Proteinase: Trans-Cleavage Requirements And Processing Kinetics</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>8147</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">7966606</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><name><surname>Bartenschlager</surname><given-names>R</given-names></name><name><surname>Ahlborn-Laake</surname><given-names>L</given-names></name><name><surname>Mous</surname><given-names>J</given-names></name><name><surname>Jacobsen</surname><given-names>H</given-names></name><article-title>Kinetic And Structural Analyses Of Hepatitis C Virus Polyprotein Processing</article-title><source>J Virol</source><year>1994</year><volume>68</volume><fpage>5045</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">8035505</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><name><surname>Failla</surname><given-names>C</given-names></name><name><surname>Tomei</surname><given-names>L</given-names></name><name><surname>De Francesco</surname><given-names>R</given-names></name><article-title>An Amino-Terminal Domain Of The Hepatitis C Virus Ns3 Protease Is Essential For Interaction With Ns4a</article-title><source>J Virol</source><year>1995</year><volume>69</volume><fpage>1769</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">7853516</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><name><surname>Lohmann</surname><given-names>V</given-names></name><name><surname>K&#x000f6;rner</surname><given-names>F</given-names></name><name><surname>Koch</surname><given-names>JO</given-names></name><name><surname>Herian</surname><given-names>U</given-names></name><name><surname>Theilmann</surname><given-names>L</given-names></name><name><surname>Bartenschlager</surname><given-names>R</given-names></name><article-title>Replication Of Subgenomic Hepatitis C Virus Rnas In A Hepatoma Cell Line</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>110</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">10390360</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><name><surname>Raney</surname><given-names>Kd</given-names></name><name><surname>Sharma</surname><given-names>Sd</given-names></name><name><surname>Moustafa</surname><given-names>Im</given-names></name><name><surname>Cameron</surname><given-names>Ce</given-names></name><article-title>Hepatitis C Virus Non-Structural Protein 3 (Hcv Ns3): A Multifunctional Antiviral Target</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>22725</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">20457607</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><name><surname>Ingallinella</surname><given-names>P</given-names></name><name><surname>Altamura</surname><given-names>S</given-names></name><name><surname>Bianchi</surname><given-names>E</given-names></name><name><surname>Taliani</surname><given-names>M</given-names></name><name><surname>Ingenito</surname><given-names>R</given-names></name><name><surname>Cortese</surname><given-names>R</given-names></name><etal/><article-title>Potent Peptide Inhibitors Of Human Hepatitis C Virus Ns3 Protease Are Obtained By Optimizing The Cleavage Products</article-title><source>Biochemistry</source><year>1998</year><volume>37</volume><fpage>8906</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">9636032</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><name><surname>Volker</surname><given-names>B</given-names></name><name><surname>Elke</surname><given-names>B</given-names></name><name><surname>Roland</surname><given-names>M</given-names></name><name><surname>Benno</surname><given-names>W</given-names></name><name><surname>Jan Albert</surname><given-names>H</given-names></name><name><surname>Hubert</surname><given-names>Eb</given-names></name><etal/><article-title>An Amino-Terminal Amphipathic &#x00391;-Helix Mediates Membrane Association Of The Hepatitis C Virus Nonstructural Protein 5A</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>8130</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11744739</pub-id></element-citation></ref></ref-list></back></article>